HLB Life Science Obtains Tissue Bank Approval...Expands Human Tissue Graft Business
HLB Life Science announced on March 24 that it will accelerate the expansion of its human tissue graft business following its acquisition of tissue bank authorization.
This authorization follows the company’s domestic exclusive distribution agreement signed last month with Orthotech, a medical device specialist, for human tissue grafts.
The product that HLB Life Science will distribute, 'FreedomInject Refill,' is an acellular allogeneic dermal injection derived from human tissue. Utilizing skin as its primary material, this human tissue-based product is used for treating damaged ligaments, tendons, muscles, and for surgical supplementation. Because it can be stored at room temperature, it is expected to offer enhanced convenience for use in medical settings.
This product is a medical biomaterial in which cells and fat components are removed from skin-derived tissue, while extracellular matrix components such as collagen—essential for tissue regeneration—are preserved as much as possible. It is expected to be widely applicable for the reconstruction, regeneration, and recovery of damaged soft tissue and joints.
HLB Life Science anticipates that, with this tissue bank authorization, it will be able to broaden its business into a wider range of human tissue-based products. The supply targets include orthopedic, neurosurgery, obstetrics and gynecology, and urology clinics nationwide, with plans to gradually expand its distribution channels in the future.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Yoonki Baek, the CEO-designate of HLB Life Science, stated, "This tissue bank authorization is significant in that it provides a key foundation for accelerating our human tissue graft business. We will continue to create new growth engines in the field of regenerative medicine, as well as expand domestic supply."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.